Advisor Group Holdings, Inc. Anavex Life Sciences Corp. Transaction History

Advisor Group Holdings, Inc.

$52.6 Billion
Q2 2025

A detailed history of Advisor Group Holdings, Inc. transactions in Anavex Life Sciences Corp. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 37,513 shares of AVXL stock, worth $337,992. This represents 0.0% of its overall portfolio holdings.

Number of Shares

37,513

Previous 29,586 26.79%

Holding current value

$337,992

Previous $272,000 26.84%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Sep 04, 2025	BUY	$7.37 - $9.63 $58,421 - $76,337	7,927 Added 26.79%	37,513 $345,000
Q2 2025 Aug 13, 2025	SELL	$7.37 - $9.63 $90,518 - $118,275	-12,282 Reduced 29.34%	29,586 $272,000
Q1 2025 May 12, 2025	BUY	$7.85 - $13.46 $304,839 - $522,692	38,833 Added 1279.51%	41,868 $359,000
Q4 2024 Jun 06, 2025	SELL	$5.11 - $12.56 $53,072 - $130,448	-10,386 Reduced 24.81%	31,482 $338,000
Q4 2024 Feb 07, 2025	SELL	$5.11 - $12.56 $29,377 - $72,207	-5,749 Reduced 65.45%	3,035 $32,000
Q3 2024 Nov 13, 2024	BUY	$4.11 - $7.04 $26,493 - $45,379	6,446 Added 275.71%	8,784 $49,000
Q2 2024 Aug 13, 2024	SELL	$3.39 - $5.02 $36,361 - $53,844	-10,726 Reduced 82.1%	2,338 $9,000
Q1 2024 May 10, 2024	SELL	$4.55 - $6.75 $38,474 - $57,078	-8,456 Reduced 39.29%	13,064 $66,000
Q4 2023 Feb 12, 2024	BUY	$5.04 - $9.95 $43,298 - $85,480	8,591 Added 66.45%	21,520 $200,000
Q3 2023 Nov 13, 2023	SELL	$6.55 - $9.37 $1,395 - $1,995	-213 Reduced 1.62%	12,929 $84,000
Q2 2023 Aug 10, 2023	SELL	$7.66 - $9.5 $12,654 - $15,694	-1,652 Reduced 11.17%	13,142 $106,000
Q1 2023 May 12, 2023	SELL	$8.32 - $11.75 $15,342 - $21,667	-1,844 Reduced 11.08%	14,794 $126,000
Q4 2022 Feb 10, 2023	BUY	$7.65 - $14.43 $54,047 - $101,947	7,065 Added 73.8%	16,638 $154,000
Q3 2022 Nov 14, 2022	SELL	$8.9 - $12.86 $16,135 - $23,315	-1,813 Reduced 15.92%	9,573 $99,000
Q2 2022 Aug 10, 2022	SELL	$7.31 - $12.84 $41,264 - $72,481	-5,645 Reduced 33.15%	11,386 $114,000
Q1 2022 May 04, 2022	SELL	$9.74 - $17.69 $366,857 - $666,293	-37,665 Reduced 68.86%	17,031 $294,000
Q3 2021 Nov 05, 2021	BUY	$16.82 - $25.75 $381,713 - $584,370	22,694 Added 70.91%	54,696 $981,000
Q2 2021 Aug 02, 2021	BUY	$10.16 - $28.86 $222,067 - $630,793	21,857 Added 215.45%	32,002 $722,000
Q1 2021 May 13, 2021	BUY	$5.17 - $16.13 $19,428 - $60,616	3,758 Added 58.84%	10,145 $152,000
Q4 2020 Feb 10, 2021	SELL	$4.01 - $7.58 $15,438 - $29,183	-3,850 Reduced 37.61%	6,387 $35,000
Q3 2020 Nov 12, 2020	SELL	$3.8 - $5.0 $10,450 - $13,750	-2,750 Reduced 21.18%	10,237 $46,000
Q2 2020 Aug 14, 2020	SELL	$2.62 - $5.2 $1,179 - $2,340	-450 Reduced 3.35%	12,987 $64,000
Q1 2020 May 18, 2020	BUY	$2.38 - $5.81 $31,980 - $78,068	13,437 New	13,437 $42,000

Others Institutions Holding AVXL

# of Institutions

196

Shares Held

32M

Call Options Held

1.16M

Put Options Held

804K

View Full List

About ANAVEX LIFE SCIENCES CORP.

Ticker AVXL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,942,800
Market Cap $702M
Description
Anavex Life Sciences Corp., a clinical stage biopharmaceutical company, engages in the development of drug candidates for the treatment of central nervous system (CNS) diseases. Its lead drug candidate is ANAVEX 2-73, which is in Phase III clinical trial for the treatment of Alzheimer's disease; Phase III clinical trial to treat pediatric patien...

More about AVXL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisor Group Holdings, Inc. with notifications on news.

Account

Advisor Group Holdings, Inc. Anavex Life Sciences Corp. Transaction History